Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In the wake of congressional hearings levying conflict of interest allegations at top scientists at the NIH, the director, Elias Zerhouni, has announced new restrictions on the types of paid consulting agreements federal scientists can accept with pharmaceutical and biotechnology companies.

NIH announces new outside work restrictions